Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp Edibles
Edibles Launch Follows Earnings Turnaround as U.S. Rescheduling Hopes Drive Sector Re-rating
Herbal Dispatch Inc. has launched "Chomp Edibles," its first dedicated cannabis edibles brand, positioning itself in the accessible premium category with flavors including Grape and Cherry Coke. The rollout includes various dosing formats (10mg single unit, 5mg per unit) and master packs designed to align with regulatory changes. Distribution is available through medical/veteran platforms and select wholesale channels across Canada. This launch follows a Q4 2025 earnings report showing positive Adjusted EBITDA of $100,000 and full-year gross sales growth of 37% to $16.5 million. The company is also advancing U.S. market entry strategies following the HHS recommendation to reclassify cannabis from Schedule I to Schedule III, aiming for an asset-light model focused on medical channels.
The launch of Chomp Edibles represents incremental growth rather than a fundamental shift in valuation drivers. While edibles account for 26% of the Canadian market and offer higher margins, this product expansion was anticipated under the December 2025 Strategic Business Plan which outlined "New Product Launches" as a priority. The material catalysts remain the Q4 earnings turnaround (positive EBITDA) and the potential U.S. rescheduling to Schedule III, both of which occurred in late April 2026 immediately preceding this release. The stock price has not reacted significantly to the edibles news alone, trading flat at $0.06 following a broader correction from February highs ($0.12). This suggests the market views the product launch as expected execution rather than new alpha generation.
Herbal Dispatch Inc. operates as a cannabis distribution company focusing on medical, veteran, and recreational channels in Canada, alongside international B2B exports. The flagship project is the expansion of its direct-to-consumer platform and export network to high-margin markets like Germany and Portugal. The company leverages an asset-light model for U.S. entry and utilizes e-commerce platforms (herbaldispatch.com) to drive domestic sales growth. Key operational milestones include achieving positive Q4 EBITDA and securing OTCQB listing status for improved liquidity.